Target
5-hydroxytryptamine receptor 2C
Ligand
BDBM84937
Substrate
n/a
Ki
2.8±n/a nM
Comments
PDSP_1137
Citation
 Nelson, DLLucaites, VLAudia, JENissen, JSWainscott, DB Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines. J Pharmacol Exp Ther 265:1272-9 (1993) [PubMed] 
Target
Name:
5-hydroxytryptamine receptor 2C
Synonyms:
5-HT-2C | 5-HT2C | 5-HT2C-INI | 5-HT2c VGI | 5-HTR2C | 5-hydroxytryptamine receptor 1C | 5-hydroxytryptamine receptor 2C (5-HT-2C) | 5-hydroxytryptamine receptor 2C (5HT-2C) | 5HT-1C | 5HT2C_HUMAN | HTR1C | HTR2C | Serotonin (5-HT3) receptor | Serotonin 2c (5-HT2c) receptor | Serotonin Receptor 2C
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
51836.79
Organism:
Homo sapiens (Human)
Description:
P28335
Residue:
458
Sequence:
MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV
  
Inhibitor
Name:
BDBM84937
Synonyms:
6-Methylergoline-8¿¿¿¿-carboxylic acid 4-methoxycyclohexyl ester | 6-Methylergoline-8β-carboxylic acid 4-methoxycyclohexyl ester | LY 254239 | LY-254239
Type:
Small organic molecule
Emp. Form.:
C23H30N2O3
Mol. Mass.:
382.4959
SMILES:
COC1CCC(CC1)OC(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 |wU:13.24,11.11,wD:14.28,(3.85,8.25,;3.08,6.91,;3.85,5.58,;5.39,5.58,;6.16,4.25,;5.39,2.91,;3.85,2.91,;3.08,4.25,;6.16,1.58,;5.39,.24,;3.85,.24,;6.16,-1.09,;6.16,-2.63,;7.49,-3.4,;8.83,-2.63,;10.16,-3.4,;10.16,-4.94,;11.31,-5.97,;10.68,-7.38,;9.15,-7.22,;8,-8.25,;6.54,-7.77,;6.22,-6.26,;7.49,-4.94,;8.83,-5.71,;8.83,-1.09,;10.16,-.32,;7.49,-.32,)|
Structure:
Search PDB for entries with ligand similarity: